Age-related reductions are also seen in this region for mGlu2/3 binding site density (Frank et al., 2011) and for mGlu2/3 immunoreactivity in controls but not in schizophrenia subjects (Crook et al., 2002). Here, GRM2 is linked to schizophrenia.